Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Dana Alsaadi, MD

 LICENSE # 0101269173
 
Issue Date: 4/8/2020
Expiration Date: 5/31/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 5/2/2024
None Reported
Academic Appointments - Non-US
Last Updated 5/2/2024
None Reported
Publications
(up to ten in the last five years)
Last Updated 5/2/2024
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
Journal for Immunotherapy of Cancer
Volume: 6
Date: 12 2018
link.springer.com/article/10.1186/s40425-018-0461-4

Immune checkpoint inhibitor-induced colitis: A comprehensive review
World Journal of Clinical Cases
Volume: 7
Date: 02 2019
www.ncbi.nlm.nih.gov/pmc/articles/PMC6397821/

A case of checkpoint inhibitor-induced celiac disease
Journal for Immunotherapy of Cancer
Volume: 7
Date: 08 2019
jitc.biomedcentral.com/articles/10.1186/s40425-019-0694-x